Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Wave Life Sciences (WVE) Other Non-Current Liabilities (2016 - 2023)

Wave Life Sciences (WVE) has disclosed Other Non-Current Liabilities for 9 consecutive years, with $190000.0 as the latest value for Q2 2023.

  • For the quarter ending Q2 2023, Other Non-Current Liabilities changed N/A year-over-year to $190000.0, compared with a TTM value of $190000.0 through Jun 2023, changed N/A, and an annual FY2022 reading of $190000.0, changed N/A over the prior year.
  • Other Non-Current Liabilities was $190000.0 for Q2 2023 at Wave Life Sciences, roughly flat from $190000.0 in the prior quarter.
  • Across five years, Other Non-Current Liabilities topped out at $2.0 million in Q1 2019 and bottomed at $190000.0 in Q4 2022.
  • Average Other Non-Current Liabilities over 5 years is $1.0 million, with a median of $1.0 million recorded in 2021.
  • The sharpest move saw Other Non-Current Liabilities surged 113.27% in 2022, then tumbled 78.11% in 2023.
  • Year by year, Other Non-Current Liabilities stood at $1.7 million in 2019, then crashed by 72.46% to $474000.0 in 2020, then skyrocketed by 113.92% to $1.0 million in 2021, then tumbled by 81.26% to $190000.0 in 2022, then changed by 0.0% to $190000.0 in 2023.
  • Business Quant data shows Other Non-Current Liabilities for WVE at $190000.0 in Q2 2023, $190000.0 in Q1 2023, and $190000.0 in Q4 2022.